Harimata

Harimata develops innovative, scientifically-validated technologies supporting early assessment and therapy of developmental disorders in children like autism, ADHD/ADD, intellectual disability. We specialise in combining experimental psychology with artificial intelligence. Our research and development projects are conducted in line with the highest scientific standards. Our product Play.Care is a tablet-based screening test supporting early detection of autism and other neurodevelopmental disorders in children aged 2–6. _______________________ This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 756079.